Next Science® Acne Gel Shows Positive Results in the Treatment of Acne

July 1, 2016Press Releases

Next Science is excited to release the results of a randomized clinical trial revealing that Next Science Acne Gel was 67% better in improving acne versus the control. “Topical Treatment with an Agent Disruptive to P. acnes Biofilm Provides Positive Therapeutic Response: Results of a Randomized Clinical Trial” appears in the June 2016 issue of Journal of Drugs in Dermatology. The publication was supported by Next Science.

Next Science Develops Biofilm-Fighting Acne Treatment Gel

May 1, 2016In the News

Next Science Acne Treatment Gel has recently been launched in the US market. It is a topical gel treatment proven effective against moderate-to-severe acne. The gel, which contains salicylic acid, is able to breakdown the biofilm that encapsulates acne-causing bacteria within the pore, allowing for more effective, non-irritating skin treatment. Next Science has partnered with leading dermatologists, please contact us to find out where this product is available.

Next Science Wound Gel Debuts at the Symposium on Advanced Wound Care

April 16, 2016In the News

Earlier this month, Next Science attended the SAWC spring conference with the nation’s foremost experts on advanced wound care. Next Science Wound Gel was the only biofilm-focused product in attendance, and served to inform the wound care community of the significant threat that biofilms pose to wound healing, and the inadequacies of competing products against … Read More

Next Science® Announces Wound Healing Study Results by Dr. Randall Wolcott

September 1, 2015Press Releases

A leading authority in wound care has published the results of a comprehensive study focusing on biofilm disruption and its effects on chronic wound treatment. “Disrupting the biofilm matrix improves wound healing outcomes” appears in the August 2015 issue of Journal of Wound Care. The combination of standard of care plus BlastX™ showed successful treatment for 93% of wounds. This was a 40% increase in healing versus standard of care alone.